Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, Dong, Vela, Ian, Sboner, Andrea, Iaquinta, Phillip J., Karthaus, Wouter R., Gopalan, Anuradha, Dowling, Catherine, Wanjala, Jackline N. +31 more·2014·Cell

Cited by (1,000)

Items 601–700 of 1,000

  1. Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
    Zhichao Li, Haibo Xu, Yanqing Gong, Wei Chen, Yonghao Zhan, Lei Yu, Yangyang Sun, Aolin Li, Shiming He, Bao Guan et al. · 2021 · Advanced Science
  2. Precision oncology using ex vivo technology: a step towards individualised cancer care?
    Sophie Therese Williams, Greg Wells, Samantha Conroy, Hannah Gagg, Richard J. Allen, Ola Rominiyi, Thomas Helleday, Katie Hullock, Catherine E. W. Pennington, Juha Rantala et al. · 2022 · Expert Reviews in Molecular Medicine
  3. Development of glioblastoma organoids and their applications in personalized therapy
    Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang, Yanli Tan · 2023 · Cancer Biology and Medicine
  4. A decade of liver organoids: Advances in disease modeling
    Liu, Yue, Sheng, Jian-Ying, Yang, Chun-Fang, Ding, Junjun, Chan, Yun-Shen · 2023 · Clinical and Molecular Hepatology
  5. Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
    Rahul Madathiparambil Visalakshan, Mary K. Lowrey, Mauricio G. C. Sousa, Haylie R. Helms, Abrar Samiea, Carolyn E. Schutt, Joshua Michael Moreau, Luiz E. Bertassoni · 2023 · Frontiers in Immunology
  6. Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment
    Maria Kalli, Triantafyllos Stylianopoulos · 2024 · APL Bioengineering
  7. Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.
    Shabnam Ziaee, Gina Chia‐Yi Chu, Jen-Ming Huang, Shirly Sieh, Leland W.K. Chung · 2015 · PubMed Central
  8. A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon
    Dong Gao, Yu Zhan, Wei Di, Amanda R. Moore, Jessica J. Sher, Youxin Guan, Shangqian Wang, Zeda Zhang, Devan A. Murphy, Charles L. Sawyers et al. · 2016 · PLoS ONE
  9. Tracking the tumor invasion front using long-term fluidic tumoroid culture
    Koh Meng Aw Yong, Zida Li, Sofia Diana Merajver, Jianping Fu · 2017 · Scientific Reports
  10. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma
    Joon Chae Na, Jee-Hoon Kim, Sook Young Kim, Young-Ran Gu, Dae Young Jun, Hyung Ho Lee, Young Eun Yoon, Kyung Hwa Choi, Sung Joon Hong, Woong Kyu Han · 2020 · Korean journal of urology
  11. Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice
    Monica Bartucci, Anna C. Ferrari, Isaac Yi Kim, Alexander Ploß, Martin L. Yarmush, Hatem E. Sabaawy · 2016 · Frontiers in Cell and Developmental Biology
  12. Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice
    Monica Bartucci, Anna C. Ferrari, Isaac Yi Kim, Alexander Ploß, Martin L. Yarmush, Hatem E. Sabaawy · 2016 · Frontiers in Cell and Developmental Biology
  13. Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells
    Peng Li, Minli Huang, Yifan Ma, Yongbin Zhang, Changhong Shi · 2024 · Cancer Cell International
  14. Using circulating tumor cells to inform on prostate cancer biology and clinical utility
    Jing Li, Simon G. Gregory, Mariano A. García-Blanco, Andrew J. Armstrong · 2015 · Critical Reviews in Clinical Laboratory Sciences
  15. Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
    Vanathi Perumal, Tammy Corica, Arun Dharmarajan, Zhonghua Sun, Satvinder Singh Dhaliwal, Crispin R. Dass, Joshua Dass · 2019 · Cancers
  16. Environmental exposures, stem cells, and cancer
    Tasha Thong, Chanese A. Forté, Evan M. Hill, Justin A. Colacino · 2019 · Pharmacology & Therapeutics
  17. Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro
    Matthew L. Tan, Ling Lu, Claudia Fischbach · 2021 · Advanced Drug Delivery Reviews
  18. Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies
    J.H. Lee, Haeryoung Kim, Sang Hyub Lee, Ja‐Lok Ku, Jung Won Chun, Ha‐Young Seo, Soon‐Chan Kim, Woo Hyun Paik, Ji Kon Ryu, Sang Kook Lee et al. · 2021 · Gut and Liver
  19. Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved
    Yutaka Shimada, Tetsuo Sudo, Shusuke Akamatsu, Takuro Sunada, Akira Myomoto, Kiyoshi Okano, Kazuharu Shimizu · 2022 · Journal of Personalized Medicine
  20. Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
    Siyu Zhou, Jinghan Lu, Shiyang Liu, Jiaqi Shao, Zhanwei Liu, Jianjun Li, Wan’an Xiao · 2023 · Frontiers in Cell and Developmental Biology
  21. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology
    Gang Deng, Libin Ma, Meng Qi, Xiang Ju, Kang Jiang, Peiwu Jiang, Zhijian Yu · 2015 · Journal of Cancer Research and Clinical Oncology
  22. The many ways to make a luminal cell and a prostate cancer cell
    Douglas W. Strand, Andrew S. Goldstein · 2015 · Endocrine Related Cancer
  23. Generation of a C57BL/6 MYC -Driven Mouse Model and Cell Line of Prostate Cancer
    Leigh Ellis, Sheng‐Yu Ku, Qiuhui Li, Gissou Azabdaftari, Joseph Seliski, Brian M. Olson, Colleen S. Netherby, Dean G. Tang, Scott I. Abrams, David W. Goodrich et al. · 2016 · The Prostate
  24. In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood
    Zahra Eslami‐S, Luis Enrique Cortés‐Hernández, Ilias Glogovitis, Mafalda Antunes‐Ferreira, Silvia D’Ambrosi, Keerthi Kurma, Françoise Garima, Laure Cayrefourcq, Myron G. Best, Danijela Koppers‐Lalic et al. · 2023 · Frontiers in Cell and Developmental Biology
  25. Toward reproducible tumor organoid culture: focusing on primary liver cancer
    Lianming Guo, Chao Li, Weiqiang Gong · 2024 · Frontiers in Immunology
  26. KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
    Jiacheng Guo, Li Ni, Qiuli Liu, Zongyao Hao, Guanghui Zhu, Xuege Wang, Hanling Wang, Qiang Pan‐Hammarström, Beitao Xu, Ying Han et al. · 2025 · Cancer Cell
  27. The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
    Liuyue Kan, Yingyan Yu, Yaxue Wang, Lei Shi, Tingyuan Fan, Hui Chen, Chuanli Ren · 2025 · Molecular Cancer
  28. Major milestones in translational oncology
    Tommaso Antonio Dragani, Antoni Castells, Vathany Kulasingam, Eleftherios P. Diamandis, Helena Margaret Earl, Wade Thomas Iams, Christine Marie Lovly, J.P. Michiel Sedelaar, Jack A. Schalken · 2016 · BMC Medicine
  29. Cortical dynamics during cell motility are regulated by CRL3KLHL21 E3 ubiquitin ligase
    Thibault Courthéoux, Radoslav Ivanov Enchev, Fabienne Lampert, Juan Gerez, Jochen Beck, Paola Picotti, Izabela Sumara, Matthias Peter · 2016 · Nature Communications
  30. Clinical Implementation of Precision Medicine in Gastric Cancer
    Jaewook Jeon, Jae‐Ho Cheong · 2019 · Journal of the Korean Gastric Cancer Association
  31. Engineered models of tumor metastasis with immune cell contributions
    Pamela L. Graney, Daniel Naveed Tavakol, Alan G. Chramiec, Kacey Ronaldson-Bouchard, Gordana Vunjak‐Novakovic · 2021 · iScience
  32. Experimental challenges to modeling prostate cancer heterogeneity
    Teresita del N.J. Flores-Téllez, Esther Baena · 2021 · Cancer Letters
  33. Recent advances in tissue stem cells
    Xin Fu, Qiang He, Yu Tao, Mengdi Wang, Wei Wang, Yalong Wang, Qing Cissy Yu, Fang Zhang, Xiaoyu Zhang, Ye‐Guang Chen et al. · 2021 · Science China Life Sciences
  34. Metabolic Studies in Organoids: Current Applications, Opportunities and Challenges
    Elena Richiardone, Valentin Van den Bossche, Cyril Corbet · 2022 · Organoids
  35. The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells
    Jennifer Munkley, Karen E. Livermore, Urszula Lucja McClurg, Gabriela Kalna, Bridget Knight, Paul J. McCullagh, John Samuel McGrath, Malcolm C. Crundwell, Hing Y. Leung, Craig N. Robson et al. · 2015 · Oncoscience
  36. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration
    William L. Hwang, Haley M. Pleskow, David Tomoaki Miyamoto · 2018 · Advanced Drug Delivery Reviews
  37. Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity
    Changhong Shi, Xue Chen, Dengxu Tan · 2019 · Translational Andrology and Urology
  38. Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics
    Shapiro, Daniel D., Virumbrales-Muñoz, Maria, Beebe, David J., Abel, E. Jason · 2022 · Frontiers in Oncology
  39. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
    Jessica Kalla, Janette Pfneissl, Theresia Mair, Loan Tran, Gerda Egger · 2024 · Cellular Oncology
  40. A Method for Prostate and Breast Cancer Cell Spheroid Cultures Using Gelatin Methacryloyl-Based Hydrogels
    Christoph Meinert, Christina Theodoropoulos, Travis Jacob Klein, Dietmar Werner Hutmacher, Daniela Loessner · 2018 · Methods in molecular biology
  41. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management
    Pietro Fici · 2018 · Methods in molecular biology
  42. Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
    Xinpei Ci, Jun Hao, Xin Dong, Hui Xue, Rebecca Wu, Stephen Yiu Chuen Choi, Anne M. Haegert, Colin C. Collins, Xuefeng Liu, Dong Lin et al. · 2020 · Cells
  43. Establishment of PDX ‐derived salivary adenoid cystic carcinoma cell lines using organoid culture method
    Kentaro Takada, Yoshihiro Aizawa, Daisuke Sano, Ryo Okuda, Keisuke Sekine, Yasuharu Ueno, Shoji Yamanaka, Jun Aoyama, Kaname Sato, Tatsu Kuwahara et al. · 2020 · International Journal of Cancer
  44. Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy
    Razan Sheta, Magdalena Bachvarova, Marie Plante, Marie‐Claude Renaud, Alexandra Sebastianelli, Jean Gregoire, Jamilet Miranda Navarro, Ricardo Bringas, Jean‐Yves Masson, Dimcho R Bachvarov · 2020 · Journal of Translational Medicine
  45. Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
    Gerardo Botti, Maurizio Di Bonito, Monica Cantile · 2021 · PubMed Central
  46. Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
    Koji Miyabayashi, Hayato Nakagawa, Kazuhiko Koike · 2021 · Frontiers in Oncology
  47. CX-5461 Sensitizes DNA Damage Repair–proficient Castrate-resistant Prostate Cancer to PARP Inhibition
    Mitchell G. Lawrence, Laura H. Porter, Nicholas Choo, David William Pook, Jeremy Grummet, Carmel Jo Pezaro, Shahneen Kaur Sandhu, Susanne Ramm, Jennii Luu, Andrew Bakshi et al. · 2021 · Molecular Cancer Therapeutics
  48. Establishment and characterization of prostate organoids from treatment‑naïve patients with prostate cancer
    Katia Anis Cheaito, Hisham F. Bahmad, Ola Hadadeh, Hiba Msheik, Alissar Monzer, Farah Ballout, Christelle Dagher, Talar Telvizian, Nour Saheb, Ayman N. Tawil et al. · 2021 · Oncology Letters
  49. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
    Silvia De Siervi, Cristian Turato · 2023 · International Journal of Molecular Sciences
  50. Tubular organotypic culture model of human kidney
    Dae Young Jun, Sook Young Kim, Joon Chae Na, Hyung Ho Lee, Jeehoon Kim, Young Eun Yoon, Sung Joon Hong, Woong Kyu Han · 2018 · PLoS ONE
  51. Circulating tumour cell isolation, analysis and clinical application
    Xiaoli Zhang, Peipei Xie, Kai‐Tai Zhang, Wen Zhang · 2023 · Cellular Oncology
  52. Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids
    Lanxiang Huang, Yaqi Xu, Na Wang, Kezhen Yi, Xiaodan Xi, Huaqi Si, Qian Zhang, Ming Xiang, Yuan Rong, Yufeng Yuan et al. · 2023 · Small Methods
  53. Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition
    Caroline F. Ribeiro, Silvia Daniele Rodrigues, Débora Campanella Bastos, Giuseppe Nicolò Fanelli, Hubert Pakula, Marco Foiani, Giorgia Zadra, Massimo F. Loda · 2024 · Science Signaling
  54. Deciphering Cell Intrinsic Properties: A Key Issue for Robust Organoid Production
    Nathalie Picollet-D’hahan, Monika E. Dolega, Delphine Freida, Donald K. Martin, Xavier Gidrol · 2017 · Trends in biotechnology
  55. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers
    Romario Nguyen, Sarah Da Won Bae, Gang Zhou, Scott A. Read, Golo Ahlenstiel, Jacob George, Liang Qiao · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  56. Tumor organoids for cancer research and personalized medicine
    Hui Yang, Yinuo Wang, Peng Wang, Ning Zhang, Pengyuan Wang · 2021 · Cancer Biology and Medicine
  57. Application of Organoid Models in Prostate Cancer Research
    Ligui Zhou, Caiqin Zhang, Yongbin Zhang, Changhong Shi · 2021 · Frontiers in Oncology
  58. Harnessing preclinical models for the interrogation of ovarian cancer
    Tianyu Qin, Junpeng Fan, Funian Lu, Li Zhang, Chen Liu, Qiyue Xiong, Yang Zhao, Gang Chen, Chaoyang Sun · 2022 · Journal of Experimental & Clinical Cancer Research
  59. Cancer metastasis chemoprevention prevents circulating tumour cells from germination
    Xiaodong Xie, Yumei Li, Shu Lian, Yusheng Lu, Lee Jia · 2022 · Signal Transduction and Targeted Therapy
  60. Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification
    Darko Castven, Diana Becker, Carolin Czauderna, D Wilhelm, Jesper Bøje Andersen, Susanne Strand, Monika Hartmann, Stefanie Heilmann‐Heimbach, Wilfried Roth, Nils Hartmann et al. · 2018 · International Journal of Cancer
  61. Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data
    Yanyan Zhu, Shundong Cang, Bowang Chen, Yue Gu, Miaomiao Jiang, Junya Yan, Fengmin Shao, Xiaoyun Huang · 2020 · Frontiers in Oncology
  62. Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection
    Song Yi Bae, Kaylee Judith Kamalanathan, Catalina Galeano‐Garces, Badrinath R. Konety, Emmanuel S. Antonarakis, Jayant Parthasarathy, Jiarong Hong, Justin M. Drake · 2024 · Endocrinology
  63. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
    Alexandra R. Lewis, Juan W. Valle, Mairead Geraldine McNamara · 2016 · World Journal of Gastroenterology
  64. Gravin regulates centrosome function through PLK1
    Erica G. Colicino, Alice M. Garrastegui, Judy R. Freshour, Peu Santra, Dawn E. Post, Leszek Kotula, Heidi Hehnly · 2017 · Molecular Biology of the Cell
  65. Unmasking molecular profiles of bladder cancer
    Xuan‐Mei Piao, Young Joon Byun, Wun‐Jae Kim, Jayoung Kim · 2018 · Korean journal of urology
  66. Improved phosphoproteomic analysis for phosphosignaling and active-kinome profiling in Matrigel-embedded spheroids and patient-derived organoids
    Yuichi Abe, Asa Tada, Junko Isoyama, Satoshi Nagayama, Ryoji Yao, Jun Adachi, Takeshi Tomonaga · 2018 · Scientific Reports
  67. Handling and Assessment of Human Primary Prostate Organoid Culture
    Tara McCray, Zachary A. Richards, Joseph Marsili, Gail S. Prins, Larisa Nonn · 2019 · Journal of Visualized Experiments
  68. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity
    Tingting Du, Songwen Lin, Ming Hua Ji, Nina Xue, Yichen Liu, Zhihui Zhang, Kehui Zhang, Jingbo Zhang, Yan Zhang, Qinghua Wang et al. · 2020 · Cancer Letters
  69. PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery
    Gail Petuna Risbridger, Mitchell G. Lawrence, Renea A. Taylor · 2020 · Journal of the Endocrine Society
  70. The Rise of Retinal Organoids for Vision Research
    Kritika Sharma, Tim U. Krohne, Volker Busskamp · 2020 · International Journal of Molecular Sciences
  71. In Situ Vitrification of Lung Cancer Organoids on a Microwell Array
    Qiang Liu, Tian Zhao, Xianning Wang, Zhongyao Chen, Yawei Hu, Xiaofang Chen · 2021 · Micromachines
  72. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
    Revati Sharma, George Kannourakis, Prashanth Prithviraj, Nuzhat Ahmed · 2022 · Frontiers in Medicine
  73. The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
    Yaya Yu, Yan-juan Zhu, Zhenzhen Xiao, Yadong Chen, Xuesong Chang, Yi‐Hong Liu, Qing Tang, Haibo Zhang · 2022 · Biomarker Research
  74. Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
    Yuting Tang, Ting Wang, Yaowen Hu, Hongli Ji, Botao Yan, Xiarong Hu, Yunli Zeng, Yifan Hao, Weisong Xue, Zexin Chen et al. · 2023 · iScience
  75. Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines
    Radosław Polański, J. Vincent, Urszula M. Polanska, Tudor Petreuş, ERIC K. Y. TANG · 2015 · Cell Death and Disease
  76. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer
    Heng-tai Zhao, Zhonglei Lu, Frederick Bauzon, Hao Fu, Jinhua Cui, Joseph D. Locker, Liang Zhu · 2016 · Oncogene
  77. Deoxycholic acid-stimulated macrophage-derived exosomes promote spasmolytic polypeptide-expressing metaplasia in the stomach
    Xianjun Xu, Jinnian Cheng, Shengzheng Luo, Xiaoyuan Gong, Dan Huang, Jingxian Xu, Yueqin Qian, Xinjian Wan, Hui Jun Zhou · 2020 · Biochemical and Biophysical Research Communications
  78. Rapid interrogation of cancer cell of origin through CRISPR editing
    Feng, Weiran, Cao, Zhen, Lim, Pei Xin, Zhao, Huiyong, Luo, Hanzhi, Mao, Ninghui, Lee, Young Sun, Rivera, Aura Agudelo, Choi, Danielle, Wu, Chao et al. · 2021 · Proceedings of the National Academy of Sciences
  79. Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening
    Sahira Syamimi Ahmad Zawawi, Elyn Amiela Salleh, Marahaini Musa · 2024 · Exploration of Targeted Anti-tumor Therapy
  80. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
    Jun Hao, Xinpei Ci, Hui Xue, Rebecca Wu, Xin Dong, Stephen Yiu Chuen Choi, Haiqing He, Yu Wang, Fang Zhang, Sifeng Qu et al. · 2018 · European Urology
  81. An update: circulating tumor cells in head and neck cancer
    Arutha Kulasinghe, Brett G.M. Hughes, Liz Kenny, Chamindie Punyadeera · 2019 · Expert Review of Molecular Diagnostics
  82. Androgen receptor enhancer amplification in matched patient‐derived xenografts of primary and castrate‐resistant prostate cancer
    Laura H. Porter, Andrew Bakshi, David William Pook, Ashlee K. Clark, David R. Clouston, John Kourambas, MURAL Investigators, David L. Goode, Gail Petuna Risbridger, Renea A. Taylor et al. · 2021 · The Journal of Pathology
  83. Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
    Wout Devlies, Florian Handle, Gaëtan Devos, Steven Joniau, Frank Claessens · 2021 · Cancers
  84. Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma
    Akira Kazama, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Vladimir N. Bilim, Andrey V. Ugolkov, Kazuhide Saito, Yoshihiko Tomita · 2021 · Oncology Reports
  85. Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
    Jing-Wei Li, Kun Fang, L. Choppavarapu, Ke Yang, Yi-Ni Yang, Junbai Wang, Ruifeng Cao, I. Jatoi, Victor X. Jin · 2021 · Clinical Epigenetics
  86. Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing
    Annelies Van Hemelryk, Lisanne Mout, Sigrun Erkens‐Schulze, Pim J. French, Wytske M. van Weerden, Martin E. van Royen · 2021 · Biomolecules
  87. Application Progress of Organoids in Colorectal Cancer
    Lianxiang Luo, Yucui Ma, Yilin Zheng, Jiating Su, Guoxin Huang · 2022 · Frontiers in Cell and Developmental Biology
  88. Next generation patient derived tumor organoids
    Enrique Podaza, Hui–Hsuan Kuo, John Nguyen, Olivier Elemento, M. Laura Martín · 2022 · Translational research
  89. Development and characterization of patient-derived salivary gland cancer organoid cultures
    Gerben Lassche, Wim van Boxtel, Tilly Wilhelmina Aalders, Onno van Hooij, Adriana C. H. van Engen–van Grunsven, Gerald W.C.T Verhaegh, Carla M.L. van Herpen, Jack A. Schalken · 2022 · Oral Oncology
  90. Multi-compartment tumor organoids
    Meng‐Horng Lee, Gabriella C. Russo, Yohan Suryo Rahmanto, Wenxuan Du, Ashleigh J. Crawford, Pei‐Hsun Wu, Daniele M. Gilkes, Ashley L. Kiemen, Tsutomu Miyamoto, Yu Yu et al. · 2020 · Materials Today
  91. Cancer organoid applications to investigate chemotherapy resistance
    Kenji Harada, Naoya Sakamoto · 2022 · Frontiers in Molecular Biosciences
  92. Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities
    Jingyao Chen, Feifei Na · 2022 · Frontiers in Bioengineering and Biotechnology
  93. Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers
    Varadha Balaji Venkadakrishnan, Yasutaka Yamada, Kenny Weng, Osasenaga Idahor, Himisha Beltran · 2023 · Molecular Cancer Research
  94. Minor intron splicing is critical for survival of lethal prostate cancer
    Anke Augspach, Kyle D. Drake, Luca Roma, Ellen Qian, Se Ri Lee, Declan Clarke, Sushant Kumar, Muriel Jaquet, John Gallon, Marco Bolis et al. · 2023 · Molecular Cell
  95. Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer
    Xiao Li, Fei Li, Fei Ye, Haotian Guo, Wentao Chen, Jia Jin, Yiran Wang, Pengfei Dai, Huili Shi, Hongru Tao et al. · 2023 · Cell Reports
  96. Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine
    Josephine Amalia Taverna, Chia‐Nung Hung, Madison H. Williams, Ryan Williams, Meizhen Chen, Samaneh Kamali, Vaishnavi Sambandam, Cheryl Hsiang-Ling Chiu, Paweł A. Osmulski, Maria E. Gaczynska et al. · 2023 · Lung Cancer
  97. Organoids as Model Systems for Gastrointestinal Diseases: Tissue Engineering Meets Genetic Engineering
    Kristin Werner, Jürgen Weitz, Daniel E. Stange · 2016 · Current Pathobiology Reports
  98. Renal cancer: new models and approach for personalizing therapy
    Simona Di Martino, Gabriele De Luca, Ludovica Grassi, G. Federici, Romina Alfonsi, Michele Signore, Antonio Addario, Laura De Salvo, Federica Francescangeli, Massimo Sanchez et al. · 2018 · Journal of Experimental & Clinical Cancer Research
  99. Organoid in colorectal cancer: progress and challenges
    Dengbo Ji, Aiwen Wu · 2020 · Chinese Medical Journal
  100. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
    Bae, JuneSung, Choi, Yun Sik, Cho, Gunsik, Jang, Se Jin · 2022 · Cancers